Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Miklós, Szûcs"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Anikó, Maráz, Katalin, Boér, Zsófia, Dankovics, Magdolna, Dank, Erika, Lahm, Ágota, Petrányi, János, Révész, Ágnes, Ruzsa, Miklós, Szûcs, Anikó, Valikovics, Mária, Vas, Zsófia, Küronya
Publikováno v:
Magyar onkologia. 61(4)
Our aim was to assess the efficacy and adverse effects of cabazitaxel (CBZ), a chemotherapeutic agent that can be administered to patients with metastatic castrate resistant prostate cancer (mCRPC) after docetaxel (DOC) therapy. We retrospectively an
Autor:
Valentin, Brodszky, Márta, Péntek, Petra, Baji, Fanni, Rencz, Lajos, Géczi, Miklós, Szûcs, Csaba, Berczi, László, Gulácsi
Publikováno v:
Magyar onkologia. 58(3)
Enzalutamide, abiraterone-acetate, and cabazitaxel are licensed post-docetaxel treatments of metastatic castration-resistant prostate cancer (mCRPC) in Hungary. The objectives of the study were to assess the efficacy and safety of post-docetaxel enza
Autor:
Anikó, Maráz, István, Bodrogi, András, Csejtei, Magdolna, Dank, Lajos, Géczi, Zsófia, Küronya, László, Mangel, Agota, Petrányi, Miklós, Szûcs, György, Bodoky
Publikováno v:
Magyar onkologia. 57(3)
Pazopanib, a tyrosine kinase inhibitor, is one of the new registered first-line therapeutic options in the treatment of metastatic clear cell renal carcinoma. Our aim was to evaluate the efficiency and toxicity of first-line pazopanib therapy adminis
Autor:
Ferenc, Jakab, Miklós, Szûcs
Publikováno v:
Magyar onkologia. 49(1)
Autor:
Péter, Agoston, Tibor, Major, András, Somogyi, Miklós, Szûcs, Agnes, Danczig, József, Lövey, Csaba, Polgár, János, Fodor, György, Németh, Miklós, Kásler
Publikováno v:
Magyar onkologia. 48(1)
To describe the technique and early results of ultrasound (US)-guided interstitial prostate brachytherapy (BT) introduced at our institute.Between December 2001 and July 2002, ten patients with clinically localised, high risk prostate cancer were tre
Publikováno v:
Magyar onkologia. 44(3)
Complete removal of the tumour or deep invasion can be proven by repeated transurethral resection of bladder wall at the previous tumour site. Six weeks after transurethral resection of bladder tumour (TURB), in all but TaG1 cases repeated resection
Publikováno v:
Magyar onkologia. 46(3)
To report a rare case of tumour-to-tumour metastasis with differential diagnostic considerations.We report the operation of a Sylvian fissure secretory meningioma in a 48 year-old woman. The tumour was suspicious of a metastasis related to a pulmonar
Publikováno v:
Magyar onkologia. 46(2)
The authors report on a rare manifestation of soft tissue metastasis of operated colorectal cancer. Interestingly, two years after the resection a etastasis with extremely high tumor marker level (CEA, CA 19.9) was detected. Marker elevation preceded